Besifloxacin Hydrochloride Structural Formula (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)
Besivance Suspension
Product Images NDC 24208-446
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 24208-446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton.jpg (Carton)
Besivance is an ophthalmic suspension used for topical use only to treat eye infections. It contains besifloxacin 0.6% and is available in 5 mL bottles with a dropper. Each ml contains active and inactive ingredients. The usual dosage is one drop into the affected eye(s) three times a day, for 7 days. The bottle should be inverted and shaken once before use. Besivance is distributed and manufactured by Bausch & Lomb in the USA. It is important to keep Besivance away from children, stored at 15°C to 25°C, and protected from light. The neckband seal must be intact before use. The US patent information for Besivance can be found at https://patents.bausch.com.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
